Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.
Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- ChecktodayChange DetectedThe website has been updated to version 2.11.2 on October 1, 2024, following the removal of version 2.11.0 on September 19, 2024.SummaryDifference1.0%
- Check7 days agoChange DetectedThe website has been updated to version 2.11.0, while a notice regarding delays in displaying study record information has been removed.SummaryDifference4%
- Check15 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference4%
- Check22 days agoChange DetectedNew content was added on September 5, 2024, following the deletion of previous content on August 30, 2024.SummaryDifference0.6%
- Check29 days agoChange DetectedThe website has been updated to version 2.10.3 on August 30, 2024, following the removal of version 2.10.2 on August 27, 2024.SummaryDifference0.6%
- Check36 days agoChange DetectedNew content was added on August 27, 2024, following the deletions that occurred on August 13, 2024.SummaryDifference0.3%
Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.